A fresh $1.5M in Series A funding is heading to Xeris Pharmaceuticals, Inc., a biopharmaceutical company focused on improving patient lives. The growth-oriented firm develops and commercializes advanced products across a range of therapies.

Get the full Xeris Pharmaceuticals, Inc. company profile
Access contacts, investors, buying signals & more
A fresh $1.5M in Series A funding is heading to Xeris Pharmaceuticals, Inc., a biopharmaceutical company focused on improving patient lives. The growth-oriented firm develops and commercializes advanced products across a range of therapies.
Portfolio company of VentureWell

HeyBreezAI
HeyBreez AI is a no-code voice automation platform that lets businesses build and automate phone workflows using natural, human-like AI agents. ⚡ Built for real operations ⚡ No code required ⚡ Human and instant HeyBreez helps companies reduce manual load, respond faster and scale without added complexity or cost. ✨ This is the Return to Voice, built for modern business operations. 👉 Get in touch: https://heybreez.ai/contact
$2.5M Seed
today

Bower
Bower is a manufacturer in Photography and Content creation accessories. Established in 1949 Bower has always been innovative and first to market in the category with new products
$2.0M Pre-seed
today
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 | ![]() NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() IHW Council India | Series a | $35.5M | today |
| 2 | ![]() GreenPower Motor Company Inc. United States | Series a | $1.4M | today |

Unlimitech Cloud
Most companies don’t have a scaling problem. They have an architecture problem. We design AI-first software systems built to scale. Architecture-first. AI-assisted workflows. Smarter engineering systems. If your product is growing but development is slowing down, it’s time to rethink your architecture.
$1.1M Seed
today
| $7.2B |
| 1y ago |
| 3 | ![]() Illumina United States | Unknown | $7.1B | 1y ago |
| 4 | ![]() GRAIL United States | Unknown | $7.1B | 1y ago |
| 5 | ![]() RemeGen Biosciences United States | Grant | $5.6B | 7mo ago |
| 3 |
![]() Aretto India |
| Series a |
| $6.1M |
| today |
| 4 | ![]() Luma United States | Series a | $25.5M | today |
| 5 | ![]() Velaura AI United States | Series a | $110.0M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in Xeris Pharmaceuticals, Inc. and reach their contacts directly.
Start free trialCarissa H.
Senior Director, Marketing Strategy
Mike M.
Regional Business Director, Rare Disease (Endocrinology)
Unlock 8 more key decision-makers at Xeris Pharmaceuticals, Inc. with verified emails and LinkedIn.
Start free trial
TuDOC
Recently received

Shyld AI
Recently received

Cardia, Inc.
Recently received